Description
bpc 157 fda classification The just announced that they're taking steps to lift restrictions on 12 peptides โ including BPC-157 and TB-500 โ making them accessible through compounding pharmacies again. This is a HUGE step C-HealthWellness Size:5MG ๐งฌ PEPTIDES & ATHLETIC
๐งฌ PEPTIDES & ATHLETIC PERFORMANCE โ WHAT DO WE ACTUALLY KNOW? Peptides are getting a lot of attention in the fitness and performance world, but it's important to separate promising research from
Excellent customer service LOVE IT Very happy with this product and how fast it got to me I will be ordering again soon
C-HealthWellness
Size:5MG
Aggressive simultaneous protocol (higher risk) Simultaneous start (both from week 1): Tirzepatide standard titration: Same as conservative: 2.5mg โ 12.5mg over 16 weeks Cagrilintide standard titration (parallel): Weeks 1-4: 0.6mg weekly Weeks 5-8: 1.2mg weekly Weeks 9-12: 1.8mg weekly Week 13+: 2.4mg weekly Aggressive dosing table: Why this is risky: Compounding side effects from start Very difficult to tolerate High dropout risk Unclear if any additional benefit Both hitting stomach simultaneously Potential maximum weight loss: 20-30% body weight (theoretical) Example: 240 lbs โ 168-192 lbs (48-72 lbs lost) But tolerability extremely questionable Who might attempt: Exceptional GI tolerance Prior success with GLP-1s without nausea Closely monitored by physician Willing to accept high side effect risk Can afford $1,200-2,400/month Understands experimental nature Lower cagrilintide doses with tirzepatide Moderate approach: Tirzepatide: Standard titration to 10-15mg Cagrilintide: Maximum 1.2-1.8mg (lower than standard 2.4mg) Rationale: Tirzepatide doing heavy lifting already Cagrilintide just adds amylin pathway Don't need maximum cagrilintide dose Better tolerability Significantly lower cost Moderate dosing comparison: Verdict: Lower cagrilintide doses (0.6-1.2mg) might be tolerable but benefit questionable